Skip to content

Community-based Precise Management for Patients With Coronary Artery Disease

Development and Assessment of the Precise Management and Rehabilitation Model of Coronary Artery Disease Under the Hierarchical Medical System

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05344053
Enrollment
480
Registered
2022-04-25
Start date
2022-05-01
Completion date
2023-07-01
Last updated
2022-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

Coronary Artery Disease, Risk Factor Control, Community-based Management, Secondary Prevention

Brief summary

The community-based precise management for patients with coronary artery disease study is a prospective, cluster-randomized, open-labeled trial. The purpose of this trial is to test whether a community-based precise management and rehabilitation model under the hierarchical medical system could help improve the cardiovascular risk factors control in patients with coronary artery disease. Additionally, the trial will also evaluate the impact of the model on major cardiovascular adverse events in patients with coronary artery disease.

Interventions

OTHERCommunity-based precise management

The community-based precise management is a modified management strategy beyond the traditional standard community-based care under the hierarchical medical system of China. In the intervention arm, the community doctors receive training to improve their skills on coronary artery disease management. Patients will be under management for 1 year according to the strategies of community-based precise management and rehabilitation model.

OTHERStandard community-based management

The standard community-based management is the usual community-based care under the hierarchical medical system of China. In this arm, the community doctors will not receive any training on precise management strategies to improve their skills on coronary artery disease management, and patients will be under usual care for 1 year.

Sponsors

Chinese Academy of Medical Sciences, Fuwai Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with prior myocardial infarction * or receiving percutaneous coronary intervention or coronary artery bypass graft; * or coronary artery stenosis≥50% defined by coronary angiography or coronary CT angiography

Exclusion criteria

* Refuse to sign the written informed consent; * Patients without the ability to take care of themselves; * Mental disorders; * Alcoholics or drug addicts; * Cannot be followed up for any reasons; * Life expectancy\<1 year due to non-cardiovascular reasons.

Design outcomes

Primary

MeasureTime frameDescription
Status of risk factors control of coronary artery disease1 yearA composite of not smoking, blood pressure\<140/90mmHg/\<130/80mmHg for patients with diabetes, HbA1c≤7%, LDL-C\<1.8mmol/L, antiplatelet therapy, and statins use.

Secondary

MeasureTime frame
All-cause death1 year
Readmission1 year
Myocardial infarction1 year
Coronary revascularization1 year
Stroke1 year

Countries

China

Contacts

Primary ContactHaiyan Xu, MD, PhD
xuhaiyan@fuwaihospital.org8610-88396082

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026